Human medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir,ritonavir, COVID-19 virus infection,...

Human medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir,ritonavir, COVID-19 virus infection, Date of authorisation: 28/01/2022, Revision: 11, Status: Authorised Human medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir,ritonavir, COVID-19 virus infection, Date of authorisation: 28/01/2022, Revision: 11, Status: Authorised

Wil je het laatste nieuws in jouw mailbox ontvangen?
Meld je dan aan voor de nieuwsbrief.